How Have Alexion Pharmaceuticals, Inc. (ALXN) Earnings Estimates Changed?

The analysts offering 12 month price targets for Alexion Pharmaceuticals, Inc. have a median target of $166.5, with a high estimate of $180 and a low estimate of $122. The Fort Washington Investment Advisors Inc holds 4,593 shares with $559,000 value, down from 7,193 last quarter.

Alexion Pharmaceuticals, Inc is a biopharmaceutical company. About 1.74 million shares traded.

About 6.41M shares traded.

Alexion Pharmaceuticals (NASDAQ:ALXN) opened at 118.89 on Monday. It has underperformed by 34.82% the S&P500. The relative volume of the stock is 3.05, while its market cap is $26.68 Billion. The Firm operates in two divisions: Insurance, and Real estate and corporate. The Company is focused on the development and commercialization of therapeutic products. The stock's quarterly performance represents pessimistic momentum of -6.79 percent. Apg Asset Nv holds 0.01% or 55,932 shares. Assenagon Asset Management S.A. now owns 884,150 shares of the biopharmaceutical company's stock valued at $124,037,000 after buying an additional 864,967 shares during the last quarter.

In the market the company is trading down since yesterday's close of $119.66. Investors measure stock performance on the basis of a company's earnings power.

Since June 14, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity. Another trade for 10,000 shares valued at $1.17M was made by HANTSON LUDWIG on Wednesday, June 14. In this case performance of tends to percentage rate of return for a stock for a given time frame.

State Treasurer State of MI cut its stake in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Taurus Asset Mngmt Ltd Co invested in 0.35% or 18,500 shares.

Understanding Profitability at Alexion Pharmaceuticals, Inc. (ALXN) was a Moderate Buy - from a survey of 15 analysts.

07/28/2017 - Alexion Pharmaceuticals, Inc. was upgraded to "outperform" by analysts at Oppenheimer. PARVEN ALVIN S sold $97,511 worth of stock or 835 shares.

Investors sentiment increased to 1.37 in Q2 2017.

Beta values for the above stocks are 1.87, 1.27, 0.00. Wexford Capital Lp, a Connecticut-based fund reported 2,900 shares.

Shares of Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. has a 50 day moving average of 139.62 and a 200 day moving average of 128.54. Alexion Pharmaceuticals had a return on equity of 12.55% and a net margin of 14.57%. Cwm Ltd Llc holds 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have caught the attention of investors. D Scott Neal stated it has 1,200 shares. Finally, Zacks Investment Research cut shares of Alexion Pharmaceuticals from a "hold" rating to a "strong sell" rating in a research note on Wednesday, November 2nd. (NASDAQ:ALXN). Macquarie Grp Limited holds 131,994 shares. Mariner Wealth Advsrs Ltd Liability reported 5,073 shares. Panagora Asset Management owns 9,472 shares. 2,000 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Mckinley Carter Wealth Service invested in 2,316 shares.

06/23/2017 - Alexion Pharmaceuticals, Inc. had its "neutral" rating reiterated by analysts at Robert W. Baird. (NASDAQ:ALXN). Keybank Association Oh reported 0% in Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. (ALXN) is expected to post revenue of $885.65 Million in the current quarter, according to consensus of 17 analysts.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 1.9 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. Therefore 79% are positive. Alexion Pharmaceuticals Inc. has $257 highest and $82 lowest target. They now have a Dollars 170 price target on the stock.

06/15/2017 - Alexion Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at Credit Suisse. The stock has "Buy" rating by Citigroup on Tuesday, September 20. As per Tuesday, March 29, the company rating was maintained by Citigroup. More interesting news about Alexion Pharmaceuticals, Inc. Royal Bank Of Canada initiated coverage on Alexion Pharmaceuticals in a research note on Thursday, September 14th. FBR Capital has "Underperform" rating and $82 target. Guggenheim initiated the shares of CPN in report on Friday, January 29 with "Buy" rating. The company was maintained on Thursday, July 27 by Jefferies. Penserra Capital Management LLC now owns 1,248 shares of the biopharmaceutical company's stock worth $151,000 after acquiring an additional 144 shares in the last quarter. The firm earned "Buy" rating on Tuesday, August 25 by Deutsche Bank. The rating was downgraded by Morgan Stanley on Monday, February 6 to "Equal-Weight". Virtus ETF Advisers LLC now owns 4,745 shares of the biopharmaceutical company's stock worth $581,000 after buying an additional 598 shares during the last quarter.

Like this


02 November 2017
Open Enrollment for 2018 Health Care Begins
Insurance agents say their best advice is if you need help, find it. "First, the enrollment period is shortened this year".

02 November 2017
USOC reveal Ralph Lauren uniforms for Pyeongchang 2018 Closing Ceremonies
For the accessories, the team will be wearing woolen mittens and hats. Olympic and Paralympic Teams for the sixth Olympic Games running.

02 November 2017
Tyrese Gibson threatens to quit 'Fast & Furious'
I'm sorry to announce that if Dewayne is in Fast9 there will no more Roman Peirce - You mess with family and my daughters survival I mess with yours.

02 November 2017
Nioh: Complete Edition (For PC Steam 11/7)
Called "Dharmachakra Kabuto", the helmet resembles the Valve logo of a man with a valve attached to his head. Those who already have played the PS4 Pro version, this two modes should be pretty familiar.

02 November 2017
Gilead Sciences, Inc. (NASDAQ:GILD) Position Trimmed by Cadence Capital Management LLC
Appleton Prtnrs Ma holds 0.18% of its portfolio in Crown Castle International Corp. (REIT) (NYSE:CCI) for 10,915 shares. Gilead Sciences's revenue was down 13.2% compared to the same quarter a year ago . (NASDAQ: GILD ) for 301,497 shares.

02 November 2017
New Fantastic Beasts 2 image backs up popular fan theory
But Dumbledore will need help from the wizard who had thwarted Grindelwald once before, his former student Newt Scamander. This has led some to speculate that he'll actually become an ally to Newt Scamander in the sequel.

02 November 2017
Three killed, one injured in Colorado Walmart shooting
Police have since announced that the situation is no longer an active shooting, but is still an active crime scene. Police vehicles and swat have swarmed the area, apparently looking for two people suspected of firing the weapons.

02 November 2017
Russian hackers targeted emails of Ukrainian politicians
Among the targets in Russian Federation were oil tycoon-turned-Kremlin foe Mikhail Khodorkovsky and Pussy Riot's Maria Alekhina. Hackers acquired "a master list of individuals whom Russian Federation would like to spy on, embarrass, discredit or silence".

02 November 2017
Nigeria Leaps 25 Spots On Ease of Doing Business Index
The Christian Association of Nigeria (CAN) has insisted that there is an Islamisation plot by the President Muhammadu Buhari-led Federal Government.

02 November 2017
Pakistani woman kills 17 family members to escape arranged marriage
But cases of poisoning related to cases of forced marriages, still a common practice in the country, are not uncommon. But Bibi was desperately unhappy with the man she had been matched with and was, in fact, in love with someone else.